Evercore ISI initiated coverage on OnKure Therapeutics
$OKUR
Biotechnology: Pharmaceutical Preparations
Health Care
Evercore ISI initiated coverage of OnKure Therapeutics with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/30/2025 | Outperform | Evercore ISI | |
| 12/5/2024 | $33.00 | Outperform | Leerink Partners |
| 10/10/2024 | $35.00 | Outperform | Oppenheimer |